SG Americas Securities’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-26,448
| Closed | -$159K | – | 3806 |
|
|
2019
Q4 | $159K | Buy |
26,448
+11,818
| +81% | +$68.4K | ﹤0.01% | 2652 |
|
|
2019
Q3 | $53K | Sell |
14,630
-21,571
| -60% | -$83.2K | ﹤0.01% | 2805 |
|
|
2019
Q2 | $97K | Buy |
+36,201
| New | +$107K | ﹤0.01% | 2819 |
|
|
2019
Q1 | – | Sell |
-46,216
| Closed | -$73K | – | 3738 |
|
|
2018
Q4 | $73K | Buy |
+46,216
| New | +$131K | ﹤0.01% | 2776 |
|
|
2018
Q3 | – | Sell |
-20,490
| Closed | -$58K | – | 3612 |
|
|
2018
Q2 | $58K | Buy |
20,490
+8,388
| +69% | +$28.6K | ﹤0.01% | 3151 |
|
|
2018
Q1 | $45K | Buy |
12,102
+1,035
| +9% | +$3.39K | ﹤0.01% | 3091 |
|
|
2017
Q4 | $32K | Sell |
11,067
-31,162
| -74% | -$113K | ﹤0.01% | 3024 |
|
|
2017
Q3 | $190K | Buy |
42,229
+15,800
| +60% | +$70.2K | ﹤0.01% | 2626 |
|
|
2017
Q2 | $121K | Buy |
26,429
+4,144
| +19% | +$16.7K | ﹤0.01% | 2786 |
|
|
2017
Q1 | $94K | Sell |
22,285
-32,965
| -60% | -$137K | ﹤0.01% | 3012 |
|
|
2016
Q4 | $228K | Buy |
+55,250
| New | +$294K | ﹤0.01% | 2262 |
|
|
2016
Q2 | – | Sell |
-26,422
| Closed | -$204K | – | 3158 |
|
|
2016
Q1 | $204K | Buy |
+26,422
| New | +$194K | ﹤0.01% | 2193 |
|
|
2015
Q3 | – | Sell |
-19,713
| Closed | -$175K | – | 2874 |
|
|
2015
Q2 | $175K | Buy |
19,713
+1,681
| +9% | +$15.9K | ﹤0.01% | 2043 |
|
|
2015
Q1 | $178K | Sell |
18,032
-13,877
| -43% | -$173K | ﹤0.01% | 1947 |
|
|
2014
Q4 | $391K | Sell |
31,909
-9,306
| -23% | -$114K | ﹤0.01% | 1853 |
|
|
2014
Q3 | $411K | Buy |
+41,215
| New | +$383K | ﹤0.01% | 1574 |
|
|
2014
Q2 | – | Sell |
-27,400
| Closed | -$90K | – | 2785 |
|
|
2014
Q1 | $90K | Buy |
+27,400
| New | +$95.9K | ﹤0.01% | 2241 |
|
|
2013
Q4 | – | Sell |
-18,302
| Closed | -$55K | – | 3169 |
|
|
2013
Q3 | $55K | Buy |
+18,302
| New | +$125K | ﹤0.01% | 2784 |
|
SG Americas Securities's ACHN Position: Q1 2020 in Review
SG Americas Securities sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 26,448 shares — an estimated $159K sold.
SG Americas Securities first reported a position in ACHN in Q3 2013 and held it in 18 quarters. The position peaked at $411K in Q3 2014. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- SG Americas Securities reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- SG Americas Securities sold 26,448 Achillion Pharmaceuticals shares in Q1 2020, an estimated $159K.
- SG Americas Securities first reported a position in Achillion Pharmaceuticals in Q3 2013 and held it in 18 quarters.
- SG Americas Securities's Achillion Pharmaceuticals position peaked at $411K in Q3 2014.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on SG Americas Securities's 13F filing for Q1 2020, filed 30 Apr 2020.